One of the functions of macrophages is to provide a defense mechanism against tumor cells. In contrast, tumor-associated macrophages (TAMs), which represent the major inflammatory component of the stroma of many tumors, are associated with tumor progression and metastasis. TAMs, in contrast with normal macrophages, exhibit the M2 phenotype, and thereby exhibit pro-tumoral functions, including angiogenesis and matrix remodeling. This review will discuss the role of TAMs in tumor progression and provide an overview of their significant part in tumor metastasis and angiogenesis.
Adams DOMacrophages. In: Jakoby WB, Pastan IH, eds. Methods in Enzymology LVIII. New York, NY: Academic Press;1979:494-506.
2.
North RJThe concept of activated macrophage. J Immunol. 1978;121:806-809.
3.
Dima VF, Ionescu MD, Balotescu C., Dima SV, Vasiliu V., Lacky D.New approach to the adoptive immunotherapy of Walker-256 carcinosarcoma with activated macrophages combined with photodynamic therapy. Roum Arch Microbiol Immunol. 2001;60:237-256.
4.
Thiounn N., Pages F., Mejean A., Descotes JL, Fridman WH, Romet-Lemonne JLAdoptive immunotherapy for superficial bladder cancer with autologous macrophage activated killer cells. J Urol. 2002;168:2373-2376.
5.
Chen GG, Lau WY, Lai PB, et al. Activation of Kupffer cells inhibits tumor growth in a murine model system. Int J Cancer. 2002;99:713-720.
6.
Fan D., Liaw A., Denkins YM, et al. Type-1 transforming growth factor-beta differentially modulates tumoricidal activity of murine peritoneal macrophages against metastatic variants of the B16 murine melanoma. J Exp Ther Oncol. 2002;2:286-297.
7.
Chen GG, Chak EC, Chun YS, et al. Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways. J Lab Clin Med . 2003;141:190-199.
8.
Mantovani A. , Ming WJ, Balotta C., Abdeljalil B., Bottazzi B.Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor . Biochim Biophys Acta. 1986;865:59.
9.
Balkwill F., Mantovani A.Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-545.
10.
Crowther M. , Brown NJ, Bishop ET, Lewis CEMicroenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leuc Biol. 2001;70:478.
11.
Leek RD, Harris ALTumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia. 2002;7:177.
12.
Mantovani A. , Sica A., Sozzani S., Allavena P., Vecchi A., Locati M.The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-686.
13.
Sher A., Pearce E., Kaye P.Shaping the immune response to parasites: role of dendritic cells. Curr Opin Immunol. 2003;15: 421-429.
14.
Biswas SK, Gangi L., Paul S., et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood. 2006;107:2112-2122.
15.
Verreck FA, de Boer T., Langenberg DM, et al. Human IL-23 producing type 1 macrophages promote but IL-10 producing type 2 macrophages subvert immunity to (myco) bacteria. Proc Natl Acad Sci U S A. 2004;101:4560-4565.
16.
Rubella S., Lemoli RMRegulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett. 2004 ;94:11-26.
17.
Sica A., Schioppa T., Mantovani A., Allavena P.Tumor associated macrophages are a distinct M2 polarized population promoting tumor progresion: potential targets of anti-cancer therapy. Eur J Cancer. 2006;42:717-727.
18.
Dinapoli MR , Calderon CL, Lopez DMThe altered tumoricidal capacity of macrophages isolated from tumor bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med. 1996 ;183:1323-1329.
19.
Klimp AH, Hollema H., Kempinga C., van der Zee AG, de Vries EG, Daemen T.Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res . 2001;61:7305-7309.
20.
Sica A., Saccani A., Bottazzi B., et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages. J Immunol. 2000;164:762-767.
21.
Lee AH, Happerfield LC, Bobrow LG, Millis RRAngiogenesis and inflammation in invasive carcinoma of the breast . J Clin Pathol. 1997;50:669.
22.
Volodko N., Reiner A., Rudas M., Jakesz R.Tumor associated macrophages in breast cancer and their prognostic correlations . Breast. 2004;7:99-105.
23.
Murdoch C., Giannoudis A., Lewis CEMechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 2004;104:2224.
24.
Leek RD, Lewis CE, Whitehouse R., Greenall M., Clarke J., Harris ALAssociation of macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology . 1999;57:138-142.
25.
O'Sullivan C., Lewis CE, Harris AL, McGee JOD.Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet. 1993;342:148-149.
26.
Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CEExpression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol . 2000;192:150.
27.
Barbera-Guillem E., Nyhus JK, Wolford CC, Friece CR, Sampsel JWVascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis and IgG immune complexes potentiate the process. Cancer Res . 2002;62:7042-7049.
28.
Kataki A., Scheid P., Piet M., et al. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression . J Lab Clin Med. 2002;140:320-328.
29.
Blot E., Chen W., Vasse M., et al. Co-operation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. Br J Cancer. 2003;88:1207-1212.
30.
Opdenakker G. , Van-Damme J.Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine . 1992;4:251-258.
31.
Leek RD, Lewis CE, White house R., Greenall M., Clarke J., Harris ALAssociation of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996 ;56:4625.
32.
Takanami I. , Takeuchi K., Kodaira S.Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis . Oncology. 1999;57:138-142.
33.
Salvesan H. , Akslen L.Significance of tumor-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. Int J Cancer. 1999;84:539-543.
34.
van-Netten JP, Ashmead BJ, Parker RL, et al. Macrophage-tumor cell associations: a factor in metastasis of breast cancer?J Leukoc Biol. 1993;54:360-362.
35.
Hewlett G., Opitz HG, Flad HD, Schlumberger HDMacrophages/monocytes require cell-to cell contact in order to regulate the growth of a murine lymphoma cell line. J Immunol. 1979;123:2265-2269.
36.
Polverini PJ , Leibovich SJEffect of macrophage depletion on growth and neovascularization of hamster buccal pouch carcinomas. J Oral Pathol. 1987;16:436-441.
37.
Ueno T., Toi M., Saji H., et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 2000;6:3282-3289.
38.
Lin EY, Pollard JWRole of infiltered leukocytes in tumor growth and spread. Br J Cancer. 2004;90:2053-2058.
39.
Lin EY, Nguyen AV, Russell RG, Pollard JWColony-stimulating factor-1 promotes progression of mammary tumors to malignancy . J Exp Med. 2001;193:727-740.
40.
Mills CD, Shearer J., Evans R., Caldwell MDMacrophage arginine metabolism and the inhibition or stimulation of cancer . J Immunol. 1992;149:2709-2714.
41.
Flier JS, Underhill LHThe tumor necrosis factor ligand and receptor families. N Engl J Med. 1996;334:1717-1725.
42.
Gingras MC, Roussel E., Roth JA, Moser RPLittle expression of cytokine mRNA by fresh tumor-infiltrating mononuclear leukocytes from glioma and lung adenocarcinoma. Cytokine. 1995;7:580-588.
43.
Akdis CA, Blaser K.IL-10 induced energy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. 1999;13:603-609.
44.
Fidler IJ, Balch CMThe biology of cancer metastasis and implications for therapy. Curr Prob Surg. 1987;24:131-233.
Wyckoff J., Wang W., Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004;64:7022-7029.
47.
Handa T., Nakagawa M., Emoto A., et al. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol. 2000;7:263-269.
48.
Hagemann T. , Robinson SC, Schulz M., et al. Enhanced invasiveness of breast cancer cell lines upon cocultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis. 2004;25:1543-1549.
49.
Hagemann T. , Wilson J., Kulbe H., et al. Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK. J Immunol. 2005;175:1197-1205.
50.
Nielson BS, Sehested M., Kjeldsen L., Borregaard N., Rygaard J., Dano K.Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab Invest. 1997;77:345.
51.
Iurlaro M., Loverro G., Vacca A., et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma . Eur J Clin Invest. 1999;29:793.
52.
Coussens LM , Tinkle CL, Hanahan D., Werb Z.MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000;103:481-490.
53.
De Visser KE , Eichten A., Coussens LMParadoxical roles of the immune system during cancer development. Nat Rev Cancer . 2006;6:24-37.
54.
Locati M., Deuschle U., Massardi ML, et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol. 2002;168:3557-3562.
55.
Mussoni A., Riganti M., Acero R., et al. Macrophages associated with murine tumors express plasminogen activator activity. Int J Cancer. 1988;41:227-230.
56.
Sunderkotter C., Goebeler M., Schulze-Osthoff K., et al. Macrophage-derived angiogenesis factors. Pharmacol Ther. 1991 ;51:195-216.
57.
Kelly PM, Davison RS, Bliss E., McGee JOMacrophages in human breast disease: a quantitative immunohistochemical study . Br J Cancer. 1988;57:174-177.
58.
Bingle L., Brown NJ, Lewis CEThe role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J Pathol. 2002 ;196:254-265.
59.
Orre M., Rogers PAW.Macrophages and microvessel density in tumors of the ovary. Gyn Oncol. 1999;73:47-50.
60.
Vacca A., Ribatti D., Ruco L., et al. Angiogenesis extent and macrophage density increase simultaneously with pathological progression of B-cell non-Hodgkins lymphomas. Br J Cancer. 1999;79:965-970.
61.
Bingle L., Lewis CE, Corke KP, Reed MWR, Brown NJMacrophages promote angiogenesis in human breast tumor spheroids in vivo. Br J Cancer. 2006;94:101-107.
62.
Folkman J.Tumor angiogenesis: therapeutic implications. N Engl J Med . 1971;285:1182.
Dvorak HFTumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650.
65.
Xiong M., Elson G., Legarda D., Leibovich SJProduction of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate and inducible nitric oxide synthase pathway . Am J Pathol. 1998;153:587-598.
66.
Heming TA, Dave SK, Tuazon DM, et al. Effects of extracellular pH on tumor necrosis factor-α production by resident alveolar macrophages. Clin Sci (Lond). 2001;101:267-274.
67.
Blood CH, Zetter BRTumor interactions with the vasculature. Biochim Biophys Acta . 1990;1032:89-118.
68.
Talks KL, Turley H., Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2 alpha in normal human tissues, cancers and tumor-associated macrophages. Am J Pathol. 2000;157:411-421.
69.
Knowles H., Leek R., Harris ALMacrophage infiltration and angiogenesis in human malignancy. Novartis Found Symp. 2004;256:189-200.
70.
Cramer T., Yamanishi Y., Clausen B., et al. HIF-1α is essential for myeloid cell-mediated inflammation . Cell. 2003;112:645-657.
71.
Lewis CE, Pollard JWDistinct role of macrophages in different tumor microenvironments . Cancer Res. 2006;66:605-612.
72.
Ohno S., Ohno Y., Suzuki N., et al. Correlation of histological location of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res. 2004; 24:3335-3342.
73.
Burton JL, Well JM, Corke KP, et al. Macrophages accumulate in avascular hypoxia areas of prostate tumors: implications for the targeted therapeutic gene delivery to such sites . J Pathol. 2000;192:8A.
74.
Negus RP, Stamp GW, Hadley J., Balkwill FRQuantitive assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol . 1997;150:1723-1734.
75.
Raghunand N. , Gatenby RA, Gillies RJMicroenvironmental and cellular consequences of altered blood flow in tumors. Br J Radiol. 2003;76:S11.
76.
Grimshow MJ , Naylor S., Balkwill FREndothelin-Z is a hypoxia-induced autocrine survival factor for breast tumor cells. Mol Cancer Ther. 2002;1:1273.
77.
Grimshaw MJ , Wilson JL, Balkwill FREndothelin-Z is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol. 2002;32:2393.
78.
Semenza GLTargeting HIF-1 for cancer therapy. Nat Rev Cancer . 2003;3:721-732.
79.
Kodelja V., Mullor C., Tenorio S., Schebesch C., Orfanos CE, Goerdt S.Differences in angiogenic potential of classically Vs alternatively activated macrophages. Immunobiology. 1997 ;197:478.
80.
Sunderkotter C., Steinbrink K., Goebeler M., Bharadwaj R., Sorg C.Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410.
81.
Mantovani A. , Silvano S., Locati M., Allavena P., Sica A.Macrophage polarization: tumor associated macrophages (defective NF-kappa B and enhanced IRF-3/STAT 1 activation). Blood. 2006;107:2112-2122.
82.
Luqmani YA, Graham M., Coombes RCExpression of basic fibroblast growth factor, FGF R1 and FGF R2 in normal and malignant human breast and comparison with other normal tissues . Br J Cancer. 1992;66(2):273-280.
83.
Semeraro N. , Montemurro P., Conese M., et al. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer. 1990;45:251-254.
84.
Guruvayoorappan C., Kuttan G.Apoptotic effect of Biophytum sensitivum on B16F-10 cells and its regulatory effects on nitric oxide and cytokine production on tumor-associated macrophages. Integr Cancer Ther. 2007;6(4):373-380.
85.
Guruvayoorappan C., Kuttan G. Antiangiogenic effect of rutin and its regulatory effect on the production of VEGF, IL-1β and TNF-α in tumor associated macrophages. J Biol Sci. 2007;7(8): 1511-1519.
86.
Luo Y., Zhou He, Krueger J., et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 2006;116(8):2132-2141.
